EP Plenary session - Joint debate on Patents

Patentit ja kasvinjalostajien oikeudet (keskustelu)

Patents and plant breeders rights (debate)

Yhtenäisen patenttisuojan luominen - Yhtenäinen patenttisuoja - käännösjärjestelyt - Patenttikiistoja koskeva tuomioistuinjärjestelmä (keskustelu)

Creation of unitary patent protection - Unitary patent protection - Jurisdictional system for patent disputes (debate)

Olennaisesti biologisten menetelmien patentointi (keskustelu)

Patenting of essential biological processes (debate)

Workshop - Policy Departements and Administration : Stem cell Research and patenting

ENVI

Tiiviimpi yhteistyö yhtenäisen patenttisuojan luomiseksi (keskustelu)

Enhanced cooperation in the area of the creation of unitary patent protection (debate)

JURI committee meeting. Exchange of views with Romanian Presidency. Presentation of study on Essential Patents and Internet of Things, commissioned by the European Parliament's Policy Department for Citizens' Rights and Constitutional Affairs at the request of JURI committee

Public Hearing - The Unitary patent : state of play in the context of Brexit

PAPADIMOULIS, Dimitrios (GUE/NGL, GR) - EP Vice-President

Plenary session week 51 2015 in Strasbourg - Patents and plant breeders rights - Oral question

Green meeting about patenting food and GMOs

JURI committee Hearing on Patent

Andreas MAVROYIANNIS, Raffaele BALDASSARRE, Martin SCHULZ - EP President

Lex Signing: European Unitary Patent Package

Plenary session week 50 -2012  in Strasbourg - European Patent

Press conference on the campaign against the patenting of biotechnical discoveries - No Patents on Life - with Nobel Prize for Literature winner Dario FO.

Martin SCHULZ - EP President, Evelyne GEBHARDT

Evelyne GEBHARDT and  M. THEN from No patents on Seeds Hand over a letter to Martin SCHULZ EP-President

Carl SCHLYTER, Raul ROMEVA I RUEDA, Elisabeth SCHROEDTER, Isabelle DURANT, Jose BOVE, Franziska BRANTNER, Martin HAUSLING, Jean-Paul BESSET, Nikos CHRYSOGELOS, Ulrike LUNACEK, Franziska KELLER

Greens / EFA group members stage a protest against patents in the agriculture sector

JURI Committee Meeting - Enhanced cooperation in the area of the creation of unitary patent protection with regard to the applicable translation arrangements

Illustration on the EU Patent at the Belgian Intellectual Property Office.

Press Conference on Biotechnical patents by: Eva LICHTENBERGER (Greens/EFA, AT) - Vittorio PRODI (S&D, IT) - Peter LIESE (EPP, DE)  - Miroslav MIKOLJIK (EPP, SL) - Carlo CASINI (EPP, IT)

Press conference in Strasbourg  : TRIPS and access to medicines - TRIPS : The EP was due to vote on whether to grant its assent to amending the TRIPS agreement to enable developing countries to make or import generic substitutes for patented medicines

No Software Patents demonstration at the EP in Strasbourg.

No Software Patents demonstration by the GreensEFA.

MEPs wear t-shirts with a slogan that reads 'Protect innovation against software patents'

Intellectual property lies at the heart of innovation and competitiveness around the world as well as in the European Union. Intellectual property rights are protected mainly through patents, trademarks and copyright. They enable individuals and companies to earn recognition and/or financial benefit from what they invent or create. By striking the right balance between innovators and public interest, intellectual property aims to foster an environment in which creativity and innovation can flourish. But despite impressive patent activity, European businesses still encounter various challenges to register or protect patents. Restrictions: ©The material may not be edited and must be shown entirely.

EPRS - Key challenges for European patents

Parlamentti keskusteli covid-19-rokotteiden patenteista luopumisesta ja hyväksyi entistä osallistavamman Erasmus+ -ohjelman. Asialistalla oli myös ilmasto. Europarlamentaarikot hyväksyivät oikeudenmukaisen siirtymän rahaston alueiden auttamiseksi vihreässä siirtymässä. Lisäksi parlamentti kiirehtii EU:lta lisätoimia ympäristöaktivistien suojelemiseksi. Europarlamentaarikot keskustelivat myös Israelin ja Palestiinan välisen konfliktin eskaloitumisesta.

Täysistunnon kohokohdat: Covid-19-rokotteiden patentit, Erasmus+ ja ympäristöasiat

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate proposal to the WTO to waive intellectual property rights for COVID-19 vaccines, a move backed by the US administration. Extracts from the debate: statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs, Valdis DOMBROVSKIS, Executive Vice-President of the EC in charge of an Economy that works for People, Esther de LANGE (EPP, NL), Iratxe GARCÍA PÉREZ (S&D, ES), Dacian CIOLOŞ (Renew, RO), Tilly METZ (Greens/EFA, LU), Marc BOTENGA (The Left, BE), and Gilles LEBRETON (ID, FR).

Waiver of the Global Covid 19 vaccines patents: extracts from the debate

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade and by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Council and Comission

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs and by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade.

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements Council and Commission

Euroopan parlamentti on uusinut vaatimuksensa rajoittamattomasta pääsystä kasvien lisääntymismateriaaleihin. Parlamentaarikot haluavat varmistaa, että maanviljelijät kaikkialla EU:ssa voivat innovoida löytääkseen ratkaisuja ilmastokriisiin ja uusiin kasvitauteihin. Rikkaat monikansalliset yritykset eivät saisi patentoida luontoa, mikä luo monopoleja ja nostaa ruoan hintaa.

Ei patenttioikeutta luontaisesti muokatuille kasveille ja siemenille

Yhteisen EU-patentin viimeinen taival on ylämäkeä, mutta uusi yksinkertaisempi järjestelmä lupaa leikata kuluja jopa 32 000 eurolla per patentti.

Keksintöjen patentoimiskulut alemmas

Yhtenäinen EU-patentti tulee olemaan EU:n yrityksille hyvin hyödyllinen, uskoo Raffaele Baldassarre. Sophia in 't Veld kertoo, mitkä maat loukkaavat perusoikeuksia Euroopassa.

7 päivää Euroopassa: Taistelua paremmista oikeuksista ja EU-patentti

30 vuoden neuvottelujen jälkeen tämä voi olla viimeinen näytös EU-patenttiasiassa. Puhuimme saksalaismeppi Bernhard Rapkayn ja espanjalaismeppi Antonio Masip Hidalgon kanssa.

Puheenaiheena: EU-patentti, viimeinen askel?

Mepit yrittävät edetä EU-patenttiasiassa, kyseenalaistavat jäsenvaltioiden lahjomattomuuden ja kertovat näkemyksensä Espanjan pankkituesta, tilallisten vaatiessa parempaa hintaa maidosta.

EU-patentti / CIA-lennot / Espanja / Maito

Mepit tarkastelevat rauhallisesti EU:n yhteispatentin tulevaisuutta neuvoston yksipuolisen päätöksen muuttaa sovittua tekstiä aiheuttaman kohun jälkeen.

Patenttiongelmia

USA:ssa se maksaa 2 000 euroa ja Euroopassa jopa 40 000 euroa. EU:n yhteisen patentin pitäisi yksinkertaistaa ja helpottaa asiaa, mutta sen toteuttaminen on vaikeaa.

Reportteri: Keksinnön patentointi koko maanosassa

Keksintöjä voitaneen pian patentoida EU:ssa pienemmälläkin budjetilla. Ja päivän muita uutisia.

Uutiset: EU-patentti on tuloillaan

Keksintöjä voitaneen pian patentoida EU:ssa pienemmälläkin budjetilla.

25 EU-maata päätti uudistaa eurooppalaista patenttia tiiviimmän yhteistyön kautta. Onko tämä EU:n lopun alku, vai hieno tapa parantaa kilpailukykyä?

333 tulosta

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents

EP Plenary session - Joint debate on Patents